Summary
- Current Price
- As of today, STE price is $238.91, up +0.61% on
- Current Price All-Time High
- STE price is currently -11.33% below its historical high of $269.44 set on
- Market Cap
- STE current market cap is $23B, down -2.66% year-over-year
- PE Ratio
- STE current PE ratio is 29.22
- Revenue
- STE current annual revenue is $5.94B, up +8.73% year-over-year
- Next Earnings
- The next earnings release for STE is on
Profile
| Metric | Value |
|---|---|
| Full Name | STERIS plc |
| Ticker | NYSE: STE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | steris.com |
| Employees | 17,787 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $238.91 | |
| Price, 1D Change | +0.61% | |
| Market Cap | $23B | |
| TTM Dividend Yield | 1.05% | |
| PE Ratio | 29.22 | |
| Beta | 0.47 | |
| Revenue | $5.94B | |
| Revenue, 1Y Change | +8.73% | |
| EPS | $7.93 | |
| EPS, 1Y Change | +24.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.63 | |
| Next Ex-Dividend | $0.69 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $7.93 | |
| EPS Estimate | $11.17 | N/A |
| EPS Est. Change | +40.98% | N/A |
| Revenue | $5.94B | |
| Revenue Estimate | $6.37B | N/A |
| Revenue Est. Change | +7.32% | N/A |
| Current Price | $238.91 | |
| Price Target | $269.00 | - |
| Price Tgt. Change | +12.59% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.06 | $6.35 | -29.93% | |
| $10.20 | $7.93 | -22.29% | |
| $11.17 | N/A | +40.98% | |
| $12.24 | N/A | +54.37% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.45B | $5.46B | +0.21% | |
| $5.94B | $5.94B | -0.09% | |
| $6.37B | N/A | +7.32% | |
| $6.78B | N/A | +14.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -1.62% | |
| Price, 3Y | +5.14% | |
| Market Cap, 1Y | -2.66% | |
| Market Cap, 3Y | +3.73% | |
| Revenue, 1Y | +8.73% | |
| Revenue, 3Y | +30.85% | |
| EPS, 1Y | +24.91% | |
| EPS, 3Y | +642.34% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $238.91 | |
| SMA 200 | $234.37 | |
| SMA 50 | $215.55 | |
| EMA 200 | $227.18 | |
| EMA 50 | $220.24 | |
| MACD | $6.27 | |
| Beta | 0.47 | |
| ATR | $6.85 | |
| 14-Day RSI | 67.97 | |
| 10-Day Volatility | 33.07% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.63 | |
| Upcoming | $0.69 | |
| Dividend Yield | 1.03% | |
| Total Dividend | $2.46 | |
| $241.80M | ||
| 30.80% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $5.94B | |
| EPS | $7.93 | |
| Gross Profit | $2.89B | |
| Gross Margin | 44.83% | |
| Operating Income | $1.15B | |
| Operating Margin | 19.32% | |
| Net Income | $785.10M | |
| Net Margin | 13.23% | |
| EBITDA | $1.63B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.29 | |
| 2.09 | ||
| 1.54 | ||
| - | ||
| 8 | ||
| 5.37 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 29.22 | |
| 3.86 | ||
| 3.22 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $7.18B | |
| $439.60M | ||
| $10.74B | ||
| $2.39B | ||
| $3.54B | ||
| $1.15B | ||
| Total Debt | $2.09B | |
| $154.70M | ||
| $338.80M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $5.15B | ||
| $1.51B | ||
| $3.27B | ||
| $0.00 | ||
| $486.50M | ||
| $0.00 | ||
| $262.20M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.34B | ||
| -$512.50M | ||
| -$568.20M | ||
| Capex | $369.00M | |
| $972.40M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Piper Sandler | → | |
| UBS | ||
| Keybanc | → | |
| Morgan Stanley | → | |
| Keybanc | → | |
| Morgan Stanley | → | |
| Jefferies | ||
| Morgan Stanley | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with STE
FAQ
- What is the ticker symbol for STERIS plc?
- The ticker symbol for STERIS plc is NYSE:STE
- Does STERIS plc pay dividends?
- Yes, STERIS plc pays dividends. The last payment was $0.63, with an ex-dividend date on June 8, 2026
- What sector is STERIS plc in?
- STERIS plc is in the Healthcare sector
- What industry is STERIS plc in?
- STERIS plc is in the Medical Devices industry
- What country is STERIS plc based in?
- STERIS plc is headquartered in United States
- When did STERIS plc go public?
- STERIS plc initial public offering (IPO) was on June 1, 1992
- Is STERIS plc in the S&P 500?
- Yes, STERIS plc is included in the S&P 500 index
- Is STERIS plc in the NASDAQ 100?
- No, STERIS plc is not included in the NASDAQ 100 index
- Is STERIS plc in the Dow Jones?
- No, STERIS plc is not included in the Dow Jones index
- When was STERIS plc last earnings report?
- STERIS plc's most recent earnings report was on August 5, 2026
- When does STERIS plc report earnings?
- The next expected earnings date for STERIS plc is November 4, 2026
Data Sources & References
- STE Official Website www.steris.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- STE Profile on Yahoo Finance finance.yahoo.com/quote/STE
- STE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ste
